Morphofunctional changes in the kidneys under the influence of new cyanothioacetamide derivatives with anti-inflammatory properties
Heading: Pharmacology, clinical pharmacology Article type: Original article
Authors: Bibik E.Yu., Moiseeva I.Ya., Saul A.S., Ivanova E.R., Krivokolysko S.G., Yakubenko E.D.
Organization: Dahl Lugansk State University, Lugansk, Russia, Donetsk State Medical University, Donetsk, Russia, Penza State University, Saint Luka Lugansk State Medical University, Lugansk, Russia
Objective: to determine morphofunctional changes in the kidneys under the influence of new derivatives of α-cyanothioacetamide with anti-inflammatory activity in a chronic experiment. Materials and methods. 80 male rats were divided into 8 individuals in 10 groups, for 10 days they received intragastric aqueous suspensions: group 1 — control (distilled water); group 2 — indomethacin at a dose of 7 mg / kg, group 3 — paracetamol at a dose of 50 mg / kg, group 4 — acetylsalicylic acid at a dose of 50 mg / kg, 5 — nimesulide at a dose of 5 mg / kg, from 6 to 10 — dihydro pyridine derivatives at a dose of 5 mg / kg. On day 11, slaughter was performed, the levels of Na+, K+, and creatinine in the blood were determined, and histological sections of the kidneys were examined. Results. The use of indomethacin, acetylsalicylic acid, and paracetamol led to impaired renal excretory function, contributing to sodium and creatinine retention in the blood. There were no statistically significant significant differences with the indicators of the intact group in the experimental groups after administration of α-cyanothioacetamide derivatives with laboratory codes d02–123, d02–139 and d02–172. These samples also did not reveal the ability to provoke the occurrence of gross structural changes in the renal parenchyma. There was no damage to the renal corpuscles with minor tubular changes. In the group receiving the compound with the d02–123 cipher, a possible potassium-sparing diuretic effect was noted. Con clusion. α-Cyanothioacetamide derivatives with codes d02–123, d02–139 and d02–172 do not contribute to impaired renal excretory function and their structural changes.
Bibliography:
1. Patel JB, Sapra A. Nephrotoxic medications. In: Stat-Pearls. Treasure Island (FL): StatPearls Publishing, 2023.
2. Huerta C, Castellsague J, Varas-Lorenzo C, Garcia Rodriguez LA. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis. 2005;45(3):531-9. DOI:10.1053/j.ajkd.2004.12.0055
3. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol. 2020; 180:114147. DOM 0.1016/j.bcp.2020.1141472
4. Djadyk A, Kugler T, Cyba I i dr. Nefrotoksichnost' nester-oidnyh protivovospalitel'nyh preparatov: mehanizmy, klinika, profilaktika. Vrach. 2017;(11):7—11.
5. Zhiryakova AS, Denisenko NP, Kryukov AV, et al. Patients' pharmacogenetic characteristics and the risk of adverse reactions to non-steroidal anti-inflammatory drugs: Case reports. Safety and Risk of Pharmacotherapy. 2024;12(2): 178-89. DOI: 10.30895/2312-7821-2024-409
6. Rebrov АР. Pain, nsaids, and chronic kidney disease: A difficult relationship. South Russian Journal of Therapeutic Practice. 2022;3 (2):25-31. DOI: 10.21886/2712-8156-2022-3-2-25-31
7. Sadykova KZh. Porazhenie pochek posle primenenija nesteroidnyh protivovospalitel'nyh preparatov. Molodoj uchenyj.
2024;3(502): 122-5.
8. Shelukhin VA, Agafonov PV. Pathology caused by nonsteroidal anti-inflammatory drags: modern threats and alternatives (review). Therapist's Bulletin. 2021;4(51):4-23.
9. Poselugina OB. Analgesic nephropathy. A modern view on the problem. Kuban Scientific Medical Bulletin. 2019;26 (2): 191-201. DOI:10.252 07/1608-6228-2019-26-2-191-201
10. Ostroumova OD, Klepikova MV, Litvinova SN. Drug-induced acute interstitial nephritis. Siberian Medical Review. 2021 ;(4):34-50. DOI:10.20333/25000136-202-4-34-50
11. Muslimova OV, Evteev VA, Mazerkina IA. Effect of organic anion transporters on the development of nephrotoxicity in the context of NSAIDs use. Bezopasnost' i risk farmakoterapii = Safety and Risk of Pharmacotherapy. 2020;8(4): 198-204. DOI:10.30895/2312-7821-2020-8-4-198-204
12. Gusev DF, Bibik EJu, Olejnik IS, et al. Ocenka v opy-tah in vivo protivovospalitel'nyh svojstv original'nyh deriva-tov a-cianotioacetamida. Molodezhnyj Innovacionnyj Vestnik. 2024;13(S1):213-5.
13. Krivokolysko DS, Dotsenko VV, Bibik EYu, et al. New hybrid molecules based on sulfur-containing nicotinonitriles: Synthesis, analgesic activity in acetic acid-induced writhing test, and molecular docking studies. Russian Journal of Bioorganic Chemistry. 2022;48(3):628-35. DOI:10.1134/S1068162022030104
14. Narkevich AN, Vinogradov KA. Methods for determining the minimum required sample size in medical research. Social'nye aspekty zdorov'a naselenia = Social aspects of population health. 2019;65(6):10. DOI:10.21045/2071-5021-2019-65-6-10
15. Agayants IM. The basics of statistics in the world of chemistry: Processing of experimental data. Saint Petersburg: Scientific Organization of Labor, 2015; 618 p.
16. Petrie A, Sabin К. Obligatory statistics in medicine. Moscow: GEOTAR-Media, 2000; 144 p.
17. Dudareva LA, Batjushin MM, Cvetkov DS. Kliniko-jepi-demiologicheskie aspekty lekarstvennoj nefropatii, inducirovan-nye priemom nesteroidnyh protivovospalitel'nyh preparatov. Nauchnaja mysl' Kavkaza. 2012;2(70):189-93.
18. Leonova MV, Alimova ЕЕ, Eremina YuN. Dangerous combination of angiotensin converting enzyme inhibitors, diuretics, and nonsteroidal antiinflammatory drugs in clinical practice. Farmateka. 2016;19(332):69-74.
| Attachment | Size |
|---|---|
| 2025_02_210-218.pdf | 973.78 KB |




